Abstract:Background: Steroid hormones influence breast tissue development and play a role in breast carcinogenesis. Their associations with mammographic breast density (MBD), an established risk factor for breast cancer, are less clear. We, therefore, investigated the associations of steroid hormone metabolites with MBD in premenopausal women. Methods: Our study population consists of 705 premenopausal women recruited during their annual screening mammogram at the Washington University School of Medicine, St. Louis, MO. We assessed volumetric percent density (VPD), dense volume (DV), and non-dense volume (NDV) using Volpara. We assayed 54 steroid hormone metabolites from fasting blood samples at Metabolon. Linear regression models were used, after adjusting for covariates, to estimate the least square means of VPD, DV, and NDV across tertiles (T) of each metabolite. Sensitivity analysis was performed among the subset of participants with a history of oral contraceptive use (OCP). We used the Benjamini-Hochberg procedure to correct for multiple tests to control the false discovery rate (FDR) at a 5% level. Results: Five androgen metabolites (androstenediol (3beta,17beta) monosulfate 2, androstenediol (3beta,17beta) disulfate 1, 5alpha-androstan-3alpha,17beta-diol monosulfate 2, 5alpha-androstan-3alpha,17beta-diol disulfate, and 5alpha-androstan-3beta,17beta-diol disulfate) and two corticosteroid metabolites (tetrahydrocortisone glucuronide 5, and cortolone glucuronide 1) were inversely associated with VPD. Androstenediol (3beta,17beta) disulfate 1, and 5alpha-androstan-3alpha,17beta-diol disulfate displayed the strongest associations with VPD. The mean VPD decreased across tertiles of androstenediol (3beta,17beta) disulfate 1 from 9.0% in T1 to 8.5% in T2, and 7.5% in T3 (FDR p-value=0.02). Similarly, the mean VPD decreased from 8.8% in T1 to 8.4% in T2, and 7.6% in T3 of 5alpha-androstan-3alpha,17beta-diol disulfate (FDR p-value=0.03). Progestin steroid metabolites appeared to be positively associated with VPD but only 5alpha-pregnan-3beta,20alpha-diol monosulfate 2 was marginally significant after FDR correction (7.5% in T1, 8.3% in T2, and 8.8% in T3; FDR p-value=0.06). Four metabolites (three corticosteroids and one androgenic steroid) were positively associated with NDV. No metabolite was associated with DV. In sensitivity analysis limited to OCP users, mean VPDs were lower but the directions of associations were similar to those observed in the overall analysis. Conclusion: We report novel associations of corticosteroids and androgen metabolites with breast density in premenopausal women. Our findings shed important new insights into hormonal biomarkers and MBD. Citation Format: Kayode A. Matthew, Girish K. Vanapali, Kayla R. Getz, Myung S. Jeon, Chongliang Luo, Xingyi Guo, Jingqin Luo, Adetunji T. Toriola. Steroid hormone metabolites and mammographic breast density in premenopausal women [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4431.

Individual and cross media communication in converging media environments : a review of research on the antecedents and effects of communication using various media in marketing contexts

Endogenous sex hormone levels and mammographic density among postmenopausal women

Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women

Performance of the slotted impactor.

Reproductive factors and mammographic density within the International Consortium of Mammographic Density: A cross-sectional study

Mechanisms of protein solubilization in reverse micelles

A study on the association among serum insulin,IGFBP3, and endometrial cancer risk in Chinese women

Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk

Cigarette smoking and mammographic breast density in post-menopausal women from the EPIC Florence cohort

Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project

Immunohistochemical localization of calcitonin gene-related peptide and bombesin/gastrin-releasing peptide in nerve fibers of the rat, guinea pig and pig female genital organs

Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change

Distribution of mammographic density and its influential factors among Chinese women

Associations between quantitative measures of mammographic density and terminal ductal lobular unit involution in Chinese breast cancer patients

Longitudinal history of mammographic breast density and breast cancer risk by familial risk, menopausal status, and initial mammographic density level in a high risk cohort: a nested case–control study

Text message content preferences to improve buprenorphine maintenance treatment in primary care

Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography

Abstract 4431: Steroid hormone metabolites and mammographic breast density in premenopausal women

[Osseointegration of dental implants after radiotherapy for oral cancer].

Mammographic Breast Density at Breast Cancer Diagnosis and Breast Cancer-Specific Survival

Premenopausal serum androgens and breast cancer risk: a nested case-control study